We used the National Heart, Lung, and Blood Institute Limited Access Dataset of Prevention of Events with Angiotensin-Converting Enzyme Inhibition (PEACE) Trial (n = 8290) which included patients with stable coronary artery disease (CAD) and preserved ejection fraction (>40%). We identified risk factors for the development of critical peripheral arterial disease (PAD; those needing angioplasty, bypass grafting, or aneurysm repair) and formulated a risk score by multivariate analyses. A total of 220 patients (2.8%) developed critical PAD over a mean follow-up of 4.7 years. Significant predictors of critical PAD were history of intermittent claudication, smoking, hypertension (HTN), coronary-artery bypass grafting (CABG), diabetes, age, serum cholesterol, and body mass index (BMI). Incident critical PAD was associated with increased composite outcome of cardiovascular death, myocardial infarction, percutaneous transluminal coronary angioplasty, or CABG (hazard ratio 1.82, 95% CI 1.50-2.22, P < .001). Risk assessment using our score may identify CAD patients at risk for critical PAD events.
Belch JJ, Topol EJ, Agnelli G., et al. Critical issues in peripheral arterial disease detection and management: a call to action. Arch Intern Med. 2003;163(8):884-892.
2.
Criqui MH, Coughlin SS, Fronek A.Noninvasively diagnosed peripheral arterial disease as a predictor of mortality: results from a prospective study. Circulation. 1985;72(4):768-773.
3.
Leng GC, Fowkes FG, Lee AJ, Dunbar J., Housley E., Ruckley CVUse of ankle brachial pressure index to predict cardiovascular events and death: a cohort study. BMJ.1996:313(7070): 1440-1444.
4.
Cotter G., Cannon CP, McCabe CH, et al. Prior peripheral arterial disease and cerebrovascular disease are independent predictors of adverse outcome in patients with acute coronary syndromes: are we doing enough? Results from the orbofiban in patients with unstable coronary syndromes-thrombolysis in myocardial infarction (OPUS-TIMI) 16 study. Am Heart J. 2003;145(4):622-627.
5.
Saw J., Bhatt DL, Moliterno DJ, et al. The influence of peripheral arterial disease on outcomes: a pooled analysis of mortality in eight large randomized percutaneous coronary intervention trials. J Am Coll Cardiol. 2006 ;48(8):1567-1572.
6.
Sutton-Tyrrell K., Rihal C., Sellers MA, et al. Long-term prognostic value of clinically evident noncoronary vascular disease in patients undergoing coronary revascularization in the bypass angioplasty revascularization investigation (BARI). Am J Cardiol. 1998;81(4):375-381.
7.
Steg PG, Bhatt DL, Wilson PW, et al. One-year cardiovascular event rates in outpatients with atherothrombosis . JAMA. 2007; 297(11):1197-1206.
8.
Criqui MH, Langer RD, Fronek A., et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med. 1992;326(6):381-386.
9.
Heald CL, Fowkes FG, Murray GD, Price JFRisk of mortality and cardiovascular disease associated with the ankle-brachial index: systematic review. Atherosclerosis. 2006;189(1):61-69.
10.
Stoffers HE , Rinkens PE, Kester AD, Kaiser V., Knottnerus JAThe prevalence of asymptomatic and unrecognized peripheral arterial occlusive disease. Int J Epidemiol. 1996;25(2):282-290.
11.
McDermott MM , Kerwin DR, Liu K., et al. revalence and significance of unrecognized lower extremity peripheral arterial disease in general medicine practice. J Gen Intern Med. 2001; 16(6):384-390.
12.
Hirsch AT, Hiatt WRPAD awareness, risk, and treatment: new resources for survival-the USA PARTNERS program. Vasc Med. 2001;6(suppl 3):9-12.
13.
Moussa ID, Jaff MR, Mehran R., et al. Prevalence and prediction of previously unrecognized peripheral arterial disease in patients with coronary artery disease: the peripheral arterial disease in interventional patients study. Catheter Cardiovasc Interv.2009; 73(6):719-724.
14.
McDermott MM , Mehta S., Ahn H., Greenland P.Atherosclerotic risk factors are less intensively treated in patients with peripheral arterial disease than in patients with coronary artery disease. J Gen Intern Med. 1997;12(4):209-215.
15.
McDermott MM , Hahn EA, Greenland P., et al. Atherosclerotic risk factor reduction in peripheral arterial diseasea: results of a national physician survey. J Gen Intern Med. 2002;17(12): 895-904.
16.
Bhatt DL, Steg PG, Ohman EM, et al. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA. 2006;295(2):180-189.
17.
Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation. 2006;113(11):e463-e654.
18.
Axelrod DA, Diwan A., Stanley JC, et al. Cost of routine screening for carotid and lower extremity occlusive disease in patients with abdominal aortic aneurysms. J Vasc Surg. 2002;35(4):754-758.
19.
Braunwald E. , Domanski MJ, Fowler SE, et al. Angiotensin-converting-enzyme inhibition in stable coronary artery disease. N Engl J Med. 2004;351(20):2058-2068.
20.
Pfeffer MA, Domanski M., Rosenberg Y., et al. Prevention of events with angiotensin-converting enzyme inhibition (the PEACE study design). Prevention of events with angiotensin-converting enzyme inhibition. Am J Cardiol. 1998;82(3A):25H-30H.
21.
Levey AS, Bosch JP, Lewis JB, Greene T., Rogers N., Roth D.A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Ann Intern Med. 1999;130(6):461-470.
22.
Bendel RB AAComparison of stopping rules in forward ‘stepwise’ regression. J Am Stat Assoc. 1977;72(1):46-53.
23.
Hsia J., Jablonski KA, Rice MM, et al. Sudden cardiac death in patients with stable coronary artery disease and preserved left ventricular systolic function. Am J Cardiol. 2008;101(4):457-461.
24.
Murabito JM , Evans JC, Nieto K., Larson MG, Levy D., Wilson PWPrevalence and clinical correlates of peripheral arterial disease in the Framingham Offspring Study. Am Heart J. 2002; 143(6):961-965.
25.
Gillum RFPeripheral arterial occlusive disease of the extremities in the United States: hospitalization and mortality. Am Heart J. 1990;120(6Pt1):1414-1418.
26.
Murabito JM , D’Agostino RB, Silbershatz H., Wilson WFIntermittent claudication. A risk profile from The Framingham Heart Study. Circulation . 1997;96(1):44-49.
27.
Cardia G., Grisorio D., Impedovo G., Lillo A., Regina G.Plasma lipids as a risk factor in peripheral vascular disease. Angiology. 1990;41(1):19-22.
28.
Donahue RP, Orchard TJDiabetes mellitus and macrovascular complications. An epidemiological perspective . Diabetes Care. 1992;15(9):1141-1155.
29.
Norgren L., Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FGInter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg.2007; 45(supplS): S5-67.
30.
Daskalopoulou SS, Pathmarajah M., Kakkos SK, et al. Association between ankle-brachial index and risk factor profile in patients newly diagnosed with intermittent claudication. Circ J. 2008; 72(3):441-448.
31.
Criqui MH, Fronek A., Klauber MR, Barrett-Connor E., Gabriel S.The sensitivity, specificity, and predictive value of traditional clinical evaluation of peripheral arterial disease: results from non-invasive testing in a defined population. Circulation. 1985 ;71(3): 516-522.
32.
Sukhija R., Yalamanchili K., Aronow WSPrevalence of left main coronary artery disease, of three- or four-vessel coronary artery disease, and of obstructive coronary artery disease in patients with and without peripheral arterial disease undergoing coronary angiography for suspected coronary artery disease. Am J Cardiol. 2003;92(3):304-305.
33.
Bhatt DLPeripheral arterial disease in the catheterization laboratory: an underdetected and undertreated risk factor. Mayo Clin Proc. 2004;79(9):1107-1109.
34.
Doonan AL, Karha J., Carrigan TP, et al. Presence of carotid and peripheral arterial disease in patients with left main disease. Am J Cardiol. 2007 ;100(7):1087-1089.
35.
Mautner GC, Mautner SL, Roberts WCAmounts of coronary arterial narrowing by atherosclerotic plaque at necropsy in patients with lower extremity amputation. Am J Cardiol . 1992; 70(13):1147-1151.
36.
Jude EB, Oyibo SO, Chalmers N., Boulton AJPeripheral arterial disease in diabetic and nondiabetic patients: a comparison of severity and outcome. Diabetes Care. 2001 ;24(8):1433-1437.
37.
Criqui MH, Browner D., Fronek A., et al. Peripheral arterial disease in large vessels is epidemiologically distinct from small vessel disease. An analysis of risk factors. Am J Epidemiol. 1989;129(6):1110-1119.
38.
Galal W., van Gestel YR, Hoeks SE, et al. The obesity paradox in patients with peripheral arterial disease: the influence of chronic obstructive pulmonary disease. Chest . 2008.
39.
O’Hare AM, Bertenthal D., Sidawy AN, Shlipak MG, Sen S., Chren MMRenal insufficiency and use of revascularization among a national cohort of men with advanced lower extremity peripheral arterial disease. Clin J Am Soc Nephrol. 2006;1(2):297-304.
40.
Cornuz J., Sidoti Pinto C., Tevaearai H., Egger M.Risk factors for asymptomatic abdominal aortic aneurysm: systematic review and meta-analysis of population-based screening studies. Eur J Public Health. 2004;14(4):343-349.
41.
Ridker PM, Stampfer MJ, Rifai N.Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA . 2001; 285(19):2481-2485.
42.
Feringa HH, Bax JJ, van Waning VH, et al. The long-term prognostic value of the resting and postexercise ankle-brachial index. Arch Intern Med. 2006 ;166(5):529-535.
43.
Tziomalos K. , Athyros VG, Karagiannis A., Mikhailidis DPThe role of ankle brachial index and carotid intima-media thickness in vascular risk stratification. Curr Opin Cardiol.2010;25(4):394-398.
